International Cancer & Immuno-Oncology Conference 2027

A three-day hybrid congress convening oncologists, immunologists, clinical researchers and policymakers to translate breakthroughs at the bench into outcomes at the bedside.

We are delighted to invite you to attend the 3rd Edition of International Cancer & Immuno-Oncology Conference (CIOC 2027), scheduled to be held from March 15–17, 2027, in Singapore and virtually. The conference will revolve around the theme “Innovations in Cancer Research and Treatment for Better Patient Outcomes,” highlighting the latest advancements and collaborative efforts in the global fight against cancer.

This Hybrid Conference will gather a diverse group of participants, including oncologists, cancer researchers, clinicians, healthcare professionals, scientists, industry experts, and students from across the globe. It serves as a multidisciplinary platform encouraging collaboration among professionals from universities, hospitals, research institutions, and healthcare industries.

CIOC 2027 will cover a wide range of topics closely related to oncology and immuno-oncology, including Cancer Biology, Cancer Genetics, Palliative Care, Precision Medicine, Immunotherapy, Radiation Oncology, Targeted Therapies, Cancer Prevention, Pediatric Oncology, and Translational Research. It will also emphasize emerging trends such as genomics, molecular diagnostics, artificial intelligence in oncology, and novel therapeutic approaches designed to enhance patient care and outcomes.

The conference will feature an extensive scientific program, including keynote speeches, plenary sessions, oral and poster presentations, workshops, symposiums, and panel discussions. These sessions will provide attendees with opportunities to present their research, gain insights from leading experts, and engage in meaningful discussions on recent developments and future directions in cancer science.